相关实验视频

Updated: Jun 11, 2025

Analyzing Beneficial Effects of Nutritional Supplements on Intestinal Epithelial Barrier Functions During Experimental Colitis

Analyzing Beneficial Effects of Nutritional Supplements on Intestinal Epithelial Barrier Functions During Experimental Colitis

Published on: January 5, 2017

5 - 氨酸可缓解结肠炎,并通过调节小鼠肠道微生物群来保护肠道屏障功能

Jingjing Wang¹, Xiaoxin Wang¹, Mingjie Jiang²

¹Shanghai Key Laboratory of Pancreatic Diseases, Institute of Translational Medicine, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.

Naunyn-Schmiedeberg's archives of pharmacology

|October 1, 2024

概括

5 - 氨基酸 (5-ASA) 通过修复肠道屏障和调节肠道细菌,有效治疗性结肠炎. 它的抗炎作用取决于健康的肠道微生物群,强调微生物群作为治疗点.

科学领域:

胃肠病学胃肠病学
微生物学微生物学
免疫学免疫学免疫学

背景情况:

性结肠炎 (UC) 治疗通常涉及5-氨酸 (5-ASA),但其精确的抗炎机制仍然不完全理解.
肠道微生物群在5-ASA对UC疗效中的作用是一个需要进一步研究的领域.

研究的目的:

为了阐明5-ASA在硫酸 (DSS) 诱导的大肠炎中的抗炎机制.
研究5-ASA对肠道屏障完整性和肠道微生物群组成的影响.
确定5-ASA对内源性肠道微生物群的治疗作用的依赖性.

主要方法:

硫酸德克斯 (DSS) 大肠炎的小鼠模型.
评估肠道屏障功能和细胞增殖标志物 (JAM-A,奥克卢丁,Ki-67) 通过西斑,免疫光和免疫组织化学/qPCR.
16S rRNA基因测序用于肠道微生物群分析,GC-MS用于短链脂肪酸 (SCFA).
在缺乏内源性肠道微生物群的抗生素治疗小鼠中对5-ASA疗效的评估.

主要成果:

5-ASA显著缓解了DSS诱导的大肠炎,并修复了肠道屏障功能障碍.
5-ASA上调紧结蛋白 (JAM-A,奥克卢丁) 和增殖标志物Ki-67.
5-ASA调节了肠道微生物群的失调,促进有益的细菌 (Faecalibaculum, Dubosiella) 和抑制促炎性细菌 (Escherichia-Shigella, Oscillibacter).
在接受抗生素治疗的小鼠中,5-ASA增加了酸水平,其治疗作用被废除了.

结论:

在大肠炎中,5-ASA的抗炎活性取决于内源性肠道微生物群的存在.
5-ASA通过恢复肠道屏障的完整性和调节肠道微生物生态系统来发挥其治疗作用.
肠道微生物群是5-ASA介导的性结肠炎治疗中的关键和潜在的向因素.

关键词:

5 - 氨基沙酸5-氨基沙酸抗生素抗生素是一种抗生素.大肠炎是一种大肠炎.肠道屏障功能肠道屏障功能我们的肠道微生物群.

更多相关视频

Investigating the Alleviating Effects of Bacillus cereus Administration on Colitis through Gut Microbiota Modulation

Investigating the Alleviating Effects of Bacillus cereus Administration on Colitis through Gut Microbiota Modulation

Published on: July 27, 2022

Injections of Lipopolysaccharide into Mice to Mimic Entrance of Microbial-derived Products After Intestinal Barrier Breach

Injections of Lipopolysaccharide into Mice to Mimic Entrance of Microbial-derived Products After Intestinal Barrier Breach

Published on: May 2, 2018

相关概念视频

Drugs for Treatment of Ulcerative Colitis in IBD

Drugs for Treatment of Ulcerative Colitis in IBD

Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...

Inflammatory Bowel Disease IV: Pharmacological Management

Inflammatory Bowel Disease IV: Pharmacological Management

Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...